Cassandra Nan

机构：AstraZeneca (Italy), AstraZeneca (Sweden) · ORCID：0009-0002-9801-0110

发表论文 33 篇 · 总被引 840 次 · h-index 12

代表论文

SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries (2020 · Advances in Therapy · 被引 146)
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program (2020 · Advances in Therapy · 被引 123)
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma (2019 · European Respiratory Journal · 被引 64)
Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK (2020 · European Respiratory Journal · 被引 60)
Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China (2016 · Frontiers in Microbiology · 被引 58)
Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials (2018 · Open Forum Infectious Diseases · 被引 42)